Finch Therapeutics Group (FNCH) Revenue & Revenue Breakdown
Finch Therapeutics Group Revenue Highlights
Latest Revenue (Y)
$107.00K
Main Segment (Y)
Collaboration Revenue
Finch Therapeutics Group Revenue by Period
Finch Therapeutics Group Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -87.57% |
2022-12-31 | - | -95.35% |
2021-12-31 | - | 140.08% |
2020-12-31 | - | -23.98% |
2019-12-31 | - | - |
Finch Therapeutics Group Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | - | -100.00% |
2023-12-31 | - | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | -100.00% |
2023-03-31 | - | 1237.50% |
2022-12-31 | - | -94.20% |
2022-09-30 | - | -61.77% |
2022-06-30 | - | 1.98% |
2022-03-31 | - | -56.08% |
2021-12-31 | - | -92.89% |
2021-09-30 | - | 300.81% |
2021-06-30 | - | -20.35% |
2021-03-31 | - | 96.62% |
2020-12-31 | - | 2.03% |
2020-09-30 | - | -24.61% |
2020-06-30 | - | 31.08% |
2020-03-31 | - | - |
Finch Therapeutics Group Revenue Breakdown
Finch Therapeutics Group Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 22 | Dec 21 |
---|---|---|
Collaboration Revenue | - | - |
Royalties Revenue From Related Party | - | - |
Latest
Quarterly Revenue by Product
Product/Service | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
---|---|---|---|---|---|---|---|---|---|
Collaboration Revenue | - | - | - | - | - | - | - | - | - |
Latest
Finch Therapeutics Group Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
---|---|---|---|---|---|---|---|---|---|
Collaboration Revenue | - | - | - | - | - | - | - | - | - |
Latest
Finch Therapeutics Group Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HOWL | Werewolf Therapeutics | - | - |
IKNA | Ikena Oncology | - | - |
STOK | Stoke Therapeutics | - | - |
NTRB | Nutriband | - | - |
LGVN | Longeveron | - | - |
FNCH | Finch Therapeutics Group | - | - |
VRAX | Virax Biolabs Group | - | - |
DSGN | Design Therapeutics | - | - |
CCCC | C4 Therapeutics | - | - |
DBTX | Decibel Therapeutics | - | - |
REVB | Revelation Biosciences | - | - |
HILS | Tharimmune | - | - |
ELYM | Eliem Therapeutics | - | - |
RNXT | RenovoRx | - | - |
CELC | Celcuity | - | - |
GLUE | Monte Rosa Therapeutics | - | - |
EWTX | Edgewise Therapeutics | - | - |
QNRX | Quoin Pharmaceuticals | - | - |
KPRX | Kiora Pharmaceuticals | - | - |
BWV | Onconetix | - | - |
XLO | Xilio Therapeutics | - | - |